{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:21:49Z","timestamp":1793830909806,"version":"4.6.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:00:00Z","timestamp":1543881600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1245\/s10434-018-07092-y","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T11:28:59Z","timestamp":1543922939000},"page":"490-496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Restrictive Intraoperative Fluid Therapy is Associated with Decreased Morbidity and Length of Stay Following Hyperthermic Intraperitoneal Chemoperfusion"],"prefix":"10.1245","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2176-4283","authenticated-orcid":false,"given":"Ryan J.","family":"Hendrix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneel","family":"Damle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiro","family":"Spanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald H.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"7092_CR1","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"T Chua","year":"2012","unstructured":"Chua T, Moran B, Sugarbaker P, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449\u20132456.","journal-title":"J Clin Oncol."},{"key":"7092_CR2","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","volume":"21","author":"A Feldman","year":"2003","unstructured":"Feldman A, Libutti S, Pingpank J, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol. 2003;21:4560\u20134567.","journal-title":"J Clin Oncol."},{"key":"7092_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"W Driel Van","year":"2018","unstructured":"Van Driel W, Koole S, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. New Engl J Med. 2018;378:230\u201340.","journal-title":"New Engl J Med."},{"issue":"1","key":"7092_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1245\/s10434-006-9185-7","volume":"14","author":"J Esquivel","year":"2007","unstructured":"Esquivel J, Sticca R, Sugarbaker P, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol. 2007;14(1):128\u201333.","journal-title":"Ann Surg Oncol."},{"issue":"20","key":"7092_CR5","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, Van Ruth S, De Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737\u201343.","journal-title":"J Clin Oncol."},{"key":"7092_CR6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jamcollsurg.2006.12.048","volume":"204","author":"EA Levine","year":"2007","unstructured":"Levine EA, Stewart JH, Russell GB, Geisinger KR, Loggie BL, Shen P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg. 2007;204:943\u201353.","journal-title":"J Am Coll Surg."},{"issue":"1","key":"7092_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1245\/ASO.2005.08.906","volume":"12","author":"VJ Verwaal","year":"2005","unstructured":"Verwaal VJ, van Ruth S, Witkamp A, Boot H, Slooten G Van, Zoetmulder FAN. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg. 2005;12(1):9\u201312.","journal-title":"Ann Surg."},{"issue":"24","key":"7092_CR8","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1002\/cncr.25356","volume":"116","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Boutitie F, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer. 2010;116(24):5608\u201318.","journal-title":"Cancer."},{"key":"7092_CR9","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1245\/s10434-014-4147-y","volume":"22","author":"K Voltanopoulos","year":"2015","unstructured":"Voltanopoulos K, Russell G, Randle R, et al. Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 Cases. Ann Surg Oncol. 2015:22;1274\u201379.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"7092_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jamasurg.2013.3640","volume":"149","author":"M Jafari","year":"2014","unstructured":"Jafari M, Halabi W, Stamos M, et al. Surgical outcomes of hyperthermic intraperitoneal chemotherapy analysis of the american college of surgeons national surgical quality improvement program. JAMA Surg. 2014;149(2):170\u201375.","journal-title":"JAMA Surg."},{"key":"7092_CR11","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1245\/s10434-014-4297-y","volume":"22","author":"G Simkens","year":"2015","unstructured":"Simkens G, Oudheusden T, Luyer M, et al. Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2015;22:2656\u201362.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"7092_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/01.sla.0000094387.50865.23","volume":"238","author":"B Brandstrup","year":"2003","unstructured":"Brandstrup B, T\u00f8nnesen H, Beier-Holgersen R, et al. Danish Study Group on Perioperative Fluid Therapy. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg. 2003;238(5):641\u2013648.","journal-title":"Ann Surg."},{"issue":"1","key":"7092_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00000542-200507000-00008","volume":"103","author":"V Nisanevich","year":"2005","unstructured":"Nisanevich V, Felsenstein I, Almogy G, Weissman C, Einav S, Matot I. Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology. 2005;103(1):25\u201332.","journal-title":"Anesthesiology."},{"key":"7092_CR14","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1378\/chest.07-0621","volume":"132","author":"A Donati","year":"2007","unstructured":"Donati A, Loggi S, Preiser JC, et al. Goal directed intraoperative therapy reduces morbidity and length of hospital stay in high risk surgical patients. Chest. 2007;132:1817\u20131824.","journal-title":"Chest"},{"key":"7092_CR15","first-page":"R687","volume":"9","author":"R Pearse","year":"2005","unstructured":"Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennet ED: Early goal directed therapy after major surgery reduces complication and hospital stay. A randomized controlled trial. Crit Care 2005;9:R687\u2013R693.","journal-title":"A randomized controlled trial. Crit Care"},{"key":"7092_CR16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/bja\/aep279","volume":"103","author":"MT Giglio","year":"2009","unstructured":"Giglio MT, Marucci M, Testini M, Brienza N. Goal-directed haemodynamic therapy and gastrointestinal complication in major surgery: a meta-analysis of randomized controlled trial. Br J Anaesth. 2009;103:637\u2013646.","journal-title":"Br J Anaesth"},{"key":"7092_CR17","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/NEJMoa010307","volume":"345","author":"E Rivers","year":"2001","unstructured":"Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. New Engl J Med. 2001;345:1368\u201377.","journal-title":"New Engl J Med."},{"key":"7092_CR18","unstructured":"Standards for Basic Anesthetic Monitoring. Committee of Origin: Standards and Practice Parameters (Approved by the ASA House of Delegates on October 21, 1986, last amended on October 20, 2010, and last affirmed on October 28, 2016). Available at: \n                    https:\/\/www.asahq.org\/~\/media\/Sites\/ASAHQ\/Files\/Public\/Resources\/standards-guidelines\/standards-for-basic-anesthetic-monitoring.pdf\n                    \n                  . Accessed 6 May 2016."},{"key":"7092_CR19","unstructured":"User Guide for the 2016 ACS NSQIP Participant Use Data File. American College of Surgeons National Surgical Quality Improvement Program, October 2017, pp. 15\u201318."},{"issue":"2","key":"7092_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien P. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients. Ann Surg. 2004;240(2):205\u2013213.","journal-title":"Ann Surg."},{"key":"7092_CR21","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/j.1365-2044.1996.tb14998.x","volume":"51","author":"F Kanakoudis","year":"1996","unstructured":"Kanakoudis F, Petrou A, Michaloudis D, et al. Anaesthesia for intra-peritoneal perfusion of hyperthermic chemotherapy Haemodynamic changes, oxygen consumption and delivery. Anaesthesia. 1996;51:1033\u20131036.","journal-title":"Anaesthesia."},{"key":"7092_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/jso.21322","volume":"100","author":"C Schmidt","year":"2009","unstructured":"Schmidt C, Moritz S, Rath S, et al. Perioperative management of patients with cytoreductive surgery for peritoneal carcinomatosis. J Surg Oncol. 2009;100:297\u2013301.","journal-title":"J Surg Oncol."},{"key":"7092_CR23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s10434-000-0296-2","volume":"7","author":"J Esquivel","year":"2000","unstructured":"Esquivel J, Angulo F, Bland RK, et al. Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open \u201ccoliseum technique\u201d. Ann Surg Oncol. 2000;7:296\u2013300.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"7092_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/SLA.0000000000001366","volume":"263","author":"K Rollins","year":"2016","unstructured":"Rollins K, Lobo D. Intraoperative goal-directed fluid therapy in elective major abdominal surgery. Ann Surg. 2016;263(3):465\u2013476.","journal-title":"Ann Surg."},{"issue":"4","key":"7092_CR25","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s11605-015-2743-1","volume":"19","author":"L Colantonio","year":"2015","unstructured":"Colantonio L, Claroni C, Fabrizi L, et al. A randomized trial of goal directed vs standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Gastrointest Surg. 2015;19(4):722\u201329.","journal-title":"J Gastrointest Surg."},{"issue":"6","key":"7092_CR26","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1007\/s11605-015-2819-y","volume":"19","author":"F Piccioni","year":"2015","unstructured":"Piccioni F, Shigeki K, Langer M. Goal-directed therapy for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: the right approach in the right place. J Gastrointest Surg. 2015;19(6):1196\u20131197.","journal-title":"J Gastrointest Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-07092-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-07092-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-07092-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T11:11:47Z","timestamp":1576494707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-07092-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["7092"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-07092-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,4]]},"assertion":[{"value":"16 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ryan J. Hendrix, Aneel Damle, Chloe Williams, Ariana Harris, Spiro Spanakis, Donald H. Lambert, and Laura A. Lambert do not have any disclosures to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}